A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.
Adelman
James U
JU
Calhoun
Anne
A
D000328:Adult; D002227:Carbazoles / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics*; D003362:Cost-Benefit Analysis; D005260:Female; D012739:Gonadal Steroid Hormones / Q000627:therapeutic use; D006801:Humans; D008599:Menstruation Disturbances / Q000150:complications* / Q000188:drug therapy; D008881:Migraine Disorders / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics; D016896:Treatment Outcome; D014363:Tryptamines / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics*; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics
D002227:Carbazoles; D012739:Gonadal Steroid Hormones; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; D014662:Vasoconstrictor Agents; C108128:frovatriptan